Currently submitted to: JMIR Public Health and Surveillance
Date Submitted: Mar 22, 2024
Open Peer Review Period: Mar 25, 2024 - May 20, 2024
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The Association of Red Cell Distribution Width with All-cause and Cardiovascular Mortality in American Adults with Hypertension: Population-Based Prospective Cohort Study
ABSTRACT
Background:
The progression of hypertension is highly heterogeneous among populations and cost-effective biomarkers assessing the prognosis of hypertension have been rarely investigated. Recent studies have highlighted the diagnostic and prognostic potential of red cell distribution width (RDW) beyond hematologic disorders. The relationship between RDW and the prognosis of hypertension has been rarely investigated.
Objective:
This study aimed to clarify the association of RDW with all-cause and cardiovascular disease (CVD) mortality in hypertensive adults.
Methods:
This prospective cohort study included 20968 adults with hypertension from the National Health and Nutritional Examination Surveys (NHANES) 1999-2018 with mortality follow-up through December 31, 2019. The participants were grouped based on the RDW quartiles as follows: Q1(≤12.5%), Q2(12.6%–13.1%), Q3(13.2%–13.9%), and Q4(≥14.0%). Kaplan-Meier curves and Cox regressions were performed to assess the relationship between RDW and mortality risk due to all-cause and CVD. The restricted cubic spline regressions were used to profile the dose-response relationship between RDW and mortality risk. The receiver operating characteristic curves were used to examine the predictive performance of RDW for mortality risk.
Results:
During a median follow-up of 96 months, 5475 deaths were documented including 1890 due to CVD. Multivariate analysis revealed that mortality risk increased step-wise by RDW quartiles, in which the HRs (95% CIs) from Q1 to Q4 were 1.00 (reference), 1.18 (1.06-1.31), 1.41 (1.27-1.56), and 2.19 (1.94-2.48) for all-cause mortality (P for trend <.001), and those were 1.00 (reference), 1.12 (0.94-1.33), 1.35 (1.12-1.63), and 2.20 (1.75-2.75) for CVD mortality (P for trend <.001). The RCS analysis revealed S-shaped associations between RDW and all-cause and CVD mortality risk. The ROC curves demonstrated acceptable predictive performance of RDW for all-cause and CVD mortality in hypertensive adults.
Conclusions:
In American adults with hypertension, higher RDW was significantly associated with higher risks of all-cause and CVD mortality. RDW might be a promising cost-effective prognostic biomarker in the management of hypertension. Further studies are warranted to explore the potential pathophysiological mechanisms underlying the association between RDW and mortality.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.